Cancel
Todd C. Girolamo
Chief Legal Officer and Secretary
@
Prokidney
w2v1.u.hh8ww1b7@q8655x59f.0v8
Sign up to see email
Known information
- Joined ProKidney as Chief Legal Officer in March 2022
- Spent 11 years at Caladrius Biosciences, Inc., where he served as Chief Legal Officer, Senior Vice President of Corporate Development and Corporate Secretary
- Began his legal career at Cahill Gordon & Reindel in 1990 and later at Reid & Priest, practicing in areas of securities law, intellectual property, employment law, and general commercial litigation
- Spent 12 years on Wall Street in institutional equities as a series 24, 7 and 63 licensed principal at Oppenheimer & Co., CIBC World Markets, Leerink Swann (now SVB Securities LLC) and Summer Street Research Partners specializing in equity research, sales, and trading of biotechnology, pharmaceuticals and medical technology market sectors
- Served as an analyst and portfolio manager at Lion’s Path Capital managing a long-short portfolio of biopharma and med-tech equities
- Received an A.B. with honors from Harvard College
- Earned a J.D. from the University of Pennsylvania Law School
- Obtained an MBA from Columbia Business School
About Prokidney
ProKidney is a biotechnology company developing cell therapy products like REACT to transform the treatment of Chronic Kidney Disease (CKD), focusing on delaying kidney failure and reducing the need for dialysis.
Report inaccurate information
